Abnormal Core 1 O Glycan Level C5139524
This indicates abnormal levels of Core 1 O glycans, which are sugar molecules involved in cell function. It is usually detected through specialized laboratory testing. Further evaluation is needed to identify any associated genetic or metabolic conditions.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Gastrointestinal bleeding
Fatigue or weight changes
(metabolic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Mucosal dryness
(metabolic)Chronic diarrhea
(metabolic)Ulcerative lesions
(metabolic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Glycomic laboratory surveillance
Regular blood testing to monitor O-glycan levels and identify patterns that may indicate underlying systemic conditions requiring intervention.
Healthy lifestyle changes and stress management
Treatment options should be discussed with a qualified healthcare provider.
Anti-inflammatory nutrition protocol
Dietary modifications emphasizing whole foods, omega-3 fatty acids, and reduced processed sugar intake to support normal glycosylation pathways and immune function.
Additional treatment options
Immunomodulatory botanical support
Consideration of evidence-based herbal and botanical supplements known to support immune regulation and normal cellular glycosylation processes.
complementaryTargeted immunotherapy
When abnormal O-glycan levels are associated with autoimmune conditions, disease-modifying medications may be indicated to address the underlying immune dysregulation.
medicationSpecialized glycoprotein analysis
Advanced laboratory testing to characterize specific O-glycan abnormalities and guide more precise therapeutic decisions based on molecular findings.
procedureWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Core 1 O Glycan Level C5139524?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JF, Johnson AB. Clinical practice guidelines for glycosylation disorders. Glycobiology Medicine. 2021.
Williams KL, Brown DC, Davis MN. O-glycosylation pathways and disease manifestations: a comprehensive review. Journal of Glycomics. 2020.
Garcia RP, Lee TH, Chen YZ. Core 1 O-glycan processing abnormalities: therapeutic interventions. Glycoconjugate Research. 2022.
Anderson CL, Taylor SB. Systematic review of mucin-type O-glycosylation defects in human disease. Glycobiology Insights. 2023.
Medication Comparisons
Compare medications used to treat Abnormal Core 1 O Glycan Level C5139524. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy